Investingnews
Published September 22, 2026
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer | INN
Read the full story at Investingnews
Optimi Health Corp. a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the appointment of.
Surfaced by 3 Google Alerts
- Psychedelics
- MDMA
- Psychedelic press release
